Aparajita (Butterfly Pea): Benefits, Evidence, Dosage & Safety

TL;DR

Aparajita is butterfly pea, a legume vine whose blue flowers carry anthocyanin pigments called ternatins. Two small randomized trials in men found acute flower-extract drinks blunted post-meal glucose and triglyceride spikes and lifted antioxidant markers. That is the whole human file. No long-term trials exist.

What it is

Aparajita is Clitoria ternatea L., a perennial legume vine in the Fabaceae family, better known as butterfly pea. Its flowers are an intense blue because they accumulate ternatins, a series of polyacylated anthocyanin pigments, delphinidin derivatives by chemistry (Maia et al. 2025, Plants). The Ayurvedic Pharmacopoeia of India recognizes the plant in two places: Part I, Volume IV carries an "Aparajita (Leaf)" monograph for Clitoria ternatea Linn., and Part I, Volume II a monograph for the dried root, "Aparajita (Rt.)" (2017 peer-reviewed tabulation of the API Pt. I, Vol. IV monograph; API Pt. I, Vol. II text).

One separation to keep in your head: what you'll drink from this plant is the flower. The pharmacopoeial monographs cover leaf and root. Flower tea is not the same preparation as the monographed drug, and that distinction matters below.

Traditional use

The 2025 review notes that C. ternatea "has been employed in classical Indian Ayurvedic medicine for the treatment of various ailments" (Maia et al. 2025). In the food context, the flowers are used as a natural blue colorant and in beverages (same review). Traditional and food-use records, not clinical proof. The human-trial evidence follows, and it is a short section.

What modern research says

Post-meal blood sugar (RCT)

Chusak et al. 2018. Fifteen healthy young men, randomized crossover. On separate visits, each man consumed five test beverages, including 50 g sucrose in water with or without 1 g or 2 g of C. ternatea flower extract (CTE). When CTE rode along with the sucrose, postprandial plasma glucose and insulin at 30 minutes were suppressed versus sucrose alone. Antioxidant capacity rose (FRAP, ORAC, TEAC, protein thiol) and the lipid-peroxidation marker MDA fell. One reassuring detail: CTE alone did not change fasting glucose or insulin, which is to say no fasting hypoglycemia (BMC Complement Altern Med 2018).

Fifteen men. One meal. Acute effects only. Keep that scale in mind every time someone cites this trial.

Post-meal triglycerides (RCT)

Chusak et al. 2021. Sixteen overweight or obese young men, randomized, given a high-fat meal with 0, 1, or 2 g CTE, blood sampled over 6 hours. The 2 g dose reduced the incremental area under the curve (iAUC) for serum triglycerides and attenuated free fatty acids at 360 min, and improved postprandial antioxidant status (FRAP, thiol; glutathione peroxidase activity higher at 180 min). Glucose iAUC didn't budge. Inflammatory cytokines, IL-6, IL-1β, TNF-α, didn't budge either (Biology 2021).

So: post-meal triglycerides, maybe. Cholesterol, weight, inflammation: nothing.

What the evidence doesn't support

The review says it plainly, so I will too: "most available evidence comes from preclinical studies, with limited clinical validation to date." The two human trials were small, short, and acute, single-meal studies, with no long-term outcome data (Maia et al. 2025). No long-term glucose-control trials. No weight-loss trials. Nothing on fasting blood sugar beyond the acute setting.

Dosage

A 2017 peer-reviewed tabulation of the API Part I, Volume IV "Aparajita (Leaf)" monograph lists root powder 1–3 g and seed powder 1–3 g: a secondary tabulation, labeled as such, whose own row names the leaf as the monographed part. Those are powder figures, not flower-tea figures; they do not transfer to the tea. The human trials used acute beverage doses (1–2 g flower extract with a meal), not a daily therapeutic regimen, so no trial-based daily dose can be stated either. Anyone quoting you a daily aparajita dose from these trials is reading further than the data go.

Safety & contraindications

The acute trials reported no fasting hypoglycemia from the extract alone. That is a narrow safety observation, not a safety verdict. Dedicated human safety reviews are lacking, and the 2025 review explicitly calls for more human studies "to confirm the efficacy and safety" (Maia et al. 2025). There are no established safety data for pregnancy or breastfeeding: avoid use in pregnancy unless a clinician advises.

One more thing, and it matters if you're buying a product. Butterfly-pea products vary: flower teas versus root and seed powders. The tabulation's 1–3 g dose figures apply to the powders, not to teas. Do not cross the two.

FAQs

What is aparajita?

Aparajita is Clitoria ternatea L., a perennial legume vine in the Fabaceae family known as butterfly pea. Its blue flowers contain ternatins, a series of polyacylated anthocyanin pigments. The Ayurvedic Pharmacopoeia of India monographs the leaf (Pt. I, Vol. IV) and the dried root (Pt. I, Vol. II). That's the plant. The flower tea people drink is a different preparation from the monographed drug.

Does butterfly pea lower blood sugar?

In one small randomized crossover trial (15 healthy men), 1–2 g of flower extract taken with 50 g sucrose suppressed postprandial glucose and insulin at 30 minutes versus sucrose alone. A separate trial found no difference in glucose iAUC after a high-fat meal. Acute, short-term evidence only. No long-term glucose-control data exist, and I'd be suspicious of anyone who claims otherwise.

Does butterfly pea help cholesterol or weight loss?

No weight-loss trials exist. One 6-hour randomized trial in 16 overweight/obese men found 2 g of flower extract reduced the post-meal triglyceride iAUC. Total-cholesterol effects and longer-term outcomes were not studied. The honest answer: triglycerides after a single meal, possibly. Everything else is without data.

What dose of aparajita is used?

A pharmacopoeial tabulation gives root powder 1–3 g and seed powder 1–3 g (2017 tabulation). The human trials used single-meal beverage doses of 1–2 g flower extract, not a daily therapeutic dose. Keep the two apart: powder doses are not tea doses.

Is butterfly pea tea safe?

The acute trials reported no fasting hypoglycemia, but dedicated human safety reviews are lacking, and there are no established safety data for pregnancy or breastfeeding. Avoid use in pregnancy unless a clinician advises. The safety file is thin, and I won't pad it.

Sources

The Maia et al. 2025 review, "Clitoria ternatea: Perspectives on Its Application in Foods and Potential Health Benefits," in Plants, is the background for identity, ternatins, and the traditional and food-use records (PMC12609804). The glucose trial is Chusak et al.'s 2018 randomized crossover study of the acute glycemic response to C. ternatea flower beverage (BMC Complementary and Alternative Medicine; Medline abstract). The lipemia trial is Chusak et al.'s 2021 randomized study of flower extract against postprandial lipemia in overweight and obese participants (Biology; PMC8533577). The pharmacopoeial identity comes from two monographs: the 2017 peer-reviewed tabulation of the API Part I, Volume IV "Aparajita (Leaf)" monograph, which also tabulates dose figures (Journal of Current Research PDF), and the API Part I, Volume II "Aparajita (Rt.)" monograph text (journal PDF mirror).

Disclaimer

This content is for education, not medical advice. Consult your doctor before using any herb, especially if you're pregnant, breastfeeding, or taking prescription medication.